David Anderson
Angel Investor
David Anderson is a startup investor. David Anderson has over 25 years of experience, including Co-Founder and Chief Scientific Officer of Proprius Pharmaceuticals (acquired by Cypress Bioscience) where he oversaw the personalized medicine services and successful CLIA/CAP certification; Chief Scientific Officer at Celgene Corporation/Signal Research Division; Senior VicePresident of Research & Development and Co-Founder of Signal Pharmaceuticals; Senior Director of Drug Discovery and Experimental Therapeutics at Johnson & Johnson (J&J); Director of the J&J Labs at Scripps Research Institute; and Group Leader at Monsanto/GD Searle. He was a leader or on teams responsible for the development of 7 INDs, 2 NDAs and 4 drugs approved by the FDA, including J&J’s Procrit® (erythropoietin), a product that achieved peak annual sales of over $4 billion, Leustatin®, and Revlimid® for oncology and Zubrin® for veterinary arthritis. David has organized, chaired, and spoken at international conferences focused on discovery and development of novel anti-inflammatory and immunomodulatory drugs, and has also refereed articles for peer-reviewed journals such as Science and The Journal of Rheumatology. He has a Ph.D. in Medical Microbiology and Immunology from the University of Missouri-Columbia.
Last updated:
For AI agents: llms.txt
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
How do I contact David Anderson?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
